Electronic signature service Docusign beat expectations with a strong fourth-quarter earnings report, driven by its new artificial intelligence-powered platform.

U.S. equities took off at midday as it appeared Democrats in the Senate would join Republicans in approving a spending plan ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Exicure (XCUR) announced that the Australian Patent Office has issued Patent No. 2018388302, titled “GPCR Heteromer Inhibitors and Uses ...

Edgewise Therapeutics' stock soars on positive Becker Muscular Dystrophy trial results. Learn why EWTX is a promising buy with derisked programs.

Scotiabank analyst Nicholas Yulico lowered the firm’s price target on Rexford Industrial (REXR) to $47 from $48 and keeps a Sector Perform rating ...

Inc. ("Exicure" or the "Company") (Nasdaq: XCUR), announced today it received notice of a delisting determination (the "Staff Delisting Determination") from the Listing Qualifications Department of ...

It measures a company’s stock price relative to its earnings per share. Calculating the P/E ratio involves dividing the market price per share by the company’s earnings per share. A higher P/E ...

An unexpected 2.3 million barrel draw in U.S. crude stocks for last week does little for prices, as it's accompanied by a 3.9 million barrel increase in distillate fuels. "The increase in the run ...

The Company is diligently working to timely satisfy the terms of the Panel’s requests and to ensu CHICAGO, August 26, 2024--Exicure, Inc. (Nasdaq: XCUR, "the Company") today announced that it will ...